These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [Abstract] [Full Text] [Related]
13. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals. Gerber GS, Jahoda A, Bales GT, Albala DM. Tech Urol; 1997 Jan; 3(1):25-9. PubMed ID: 9170221 [Abstract] [Full Text] [Related]
14. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091 [Abstract] [Full Text] [Related]
16. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. Ghalayini IF, Al-Ghazo MA, Pickard RS. BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128 [Abstract] [Full Text] [Related]
17. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience. Kahn SA, Alphonse P, Tewari A, Narayan P. J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934 [Abstract] [Full Text] [Related]